Introduction {#s1}
============

Infections are a major cause of morbidity and mortality in hospitalized patients. Because identification of bacterial pathogens requires time for the organisms to grow, when infection is suspected empiric antimicrobial treatment is administered based upon an assessment of likely organisms [@pone.0066349-Puskarich1]--[@pone.0066349-McGarvey1]. Bacterial meningitis is a primary example of the importance of appropriate empiric therapy before culture results are known. Here, a delay in the initiation of antimicrobial therapy correlates with increased mortality in this disease [@pone.0066349-Fitch1]--[@pone.0066349-Proulx1], and antibiotics are routinely administered before cerebrospinal fluid (CSF) is obtained (the site likely to yield the pathogen). Other clinical scenarios such as febrile neutropenia, transplant associated infections, and severe sepsis also mandate that antibiotics are administered in a timely fashion and should not be delayed.

The sensitivity and timeliness of culture results are influenced by many factors, but in hospitalized patients previously administered and/or concurrent antimicrobial treatment is a commonly encountered confounding factor. When pathogens are not recovered in culture, the entire treatment course is likely to be "broad spectrum" including therapy for staphylococci, streptococci, as well as Gram negative and anaerobic bacteria. As a result, antibiotics are often used unnecessarily. Regrettably, a delay or failure in identification of pathogens impacts patient outcomes, exposes patients to the deleterious effects of extended courses of overly broad empirical antibiotics, and exacerbates the widespread problems of multidrug resistant organisms and *Clostridium difficile* associated disease.

The analysis of multilocus polymerase chain reaction (PCR) amplicons by electrospray ionization mass spectrometry (ESI/MS) on a platform in which PCR is coupled to ESI-MS is a technique that has demonstrated the capacity to detect microbes from both environmental samples and clinical patient specimens [@pone.0066349-Sampath1]--[@pone.0066349-Caliendo1]. Detection does not require correct anticipation of the organisms in advance; the technology is designed to detect unknown and unculturable organisms, and is particularly useful when multiple microbes may be present.

We performed a prospective comparison of results from conventional microbiologic testing vs. PCR/ESI-MS in cases of suspected new onset, or recurrence of infection in patients where samples were obtained after at least one dose of antibiotic treatment. Our purpose is to demonstrate that PCR/ESI-MS may have value in the clinical microbiology laboratory when cultures do not yield a pathogen. Offering clinicians relevant, timely and specific information can have significant impact on the choice of therapy, clinical decision making, and antimicrobial stewardship.

Methods {#s2}
=======

Approval was obtained from both the University of Illinois College of Medicine and St. Francis Medical Center Institutional Review Boards (IRBs) for PCR/ESI-MS testing of specimens that were submitted to the microbiology laboratory from inpatients at St. Francis Medical Center, Peoria, IL. To test if PCR/ESI-MS serves a potential role in the detection of microorganisms in specimens collected from patients following administration of antimicrobial treatment, we prospectively identified patients with suspected infection between February 10, 2011 and November 10, 2012. Patients whose specimens were collected after at least one dose of antibiotic were included in the study. Gram stains, conventional aerobic and anaerobic culture and PCR/ESI-MS were performed on all specimens. The PCR/ESI-MS test results were not available to the patients\' treatment teams and did not influence treatment decisions.

In each case, specimens were collected as part of the routine care of the patient and submitted to clinical microbiology lab at St. Francis Medical Center (Peoria, IL) for testing. After the specimen was processed by laboratory personal and all the requested tests and cultures ordered by the treating physician had been prepared, the remaining specimen was placed in storage at 4°C for subsequent PCR/ESI-MS testing. Because specimens included in this study were collected in the course of the patients medical care for diagnostic purposes, and no specimens were collected explicitly for the purposes of this study, both IRBs waived the requirement for patient informed consent.

PCR/ESI-MS was performed on all specimens. Specimens were kept in refrigeration, not frozen, and shipped overnight in a cold pack to Ibis Biosciences (Carlsbad, CA). We followed the PCR/ESI-MS protocol previously described [@pone.0066349-Kaleta1]. This PCR/ESI-MS assay is designed for detection of bacterial and *Candida* species, and is not capable of identifying invasive molds, dimorphic fungi, or viral pathogens. Consequently, immunocompromised patients, patients on chemotherapy for treatment of malignancy, or patients with HIV infection were excluded from the study. Compared to clinical samples, the assay performs with 98.7% and 96.6% concordance at the genus and species levels, respectively [@pone.0066349-Kaleta1].

For reporting results, the level of detection (LOD) was calculated as genome equivalents per PCR reaction well. Results were reported for all detections with a Q score ≥0.90 in which the LOD was above threshold, and the internal isolation control was detected. Kappa (κ) was calculated using SAS software, version 9.1 (SAS Institute) to assess the agreement between culture and PCR/ESI-MS.

Results {#s3}
=======

Conventional microbiology testing was performed on 76 specimens collected from 47 patients. Specimens included swabs, BACTEC blood culture bottles, fluid, and tissue samples that were submitted for culture from patients after initiation of antimicrobial treatment ([Table 1](#pone-0066349-t001){ref-type="table"}). The results obtained from aerobic and anaerobic cultures were compared to results of PCR/ESI-MS testing ([Table 2](#pone-0066349-t002){ref-type="table"}). PCR/ESI-MS detected probable pathogens in 20 cases in which standard microbial cultures were non-diagnostic. Results were in agreement for 38 specimens (49%); but 37% of the agreement (14 specimens) was attributed to specimens that were culture negative with no detection by PCR/ESI-MS. For patients with multiple specimens, only the culture positive specimen, when applicable, was considered for calculation of the Kappa statistic. Compared to agreement between culture and Gram stain, (κ = 0.643), agreement between culture and PCR/ESI-MS was poor (κ = 0.299).

10.1371/journal.pone.0066349.t001

###### Patients, specimens, and antimicrobial treatment.

![](pone.0066349.t001){#pone-0066349-t001-1}

  Patient                                  Age/gender/history                                                    Diagnosis                                Previous culture confirmed infection(s)                                              Specimens                                                                     Antimicrobial Treatment                                    DOT[\*](#nt101){ref-type="table-fn"}
  --------- -------------------------------------------------------------------------------- -------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ --------------------------------------
  1                                        48 year-old woman                                            Right lung abscess & empyema                                        --                                                               Pleural fluid                                                             Azithromycin Ceftriaxone Vancomycin                                            5 11 10
  2                                           26 year-old                                                          Brain                                                                                                                   CSF \#1 (from LP)                                                                  Ceftriaxone Vancomycin                                                    1 1
                                                  man                                                             abscess                                                   --                                                            CSF \#2 (from EVD)                                                Cefepime Ceftriaxone Clindamy cin Metronidazole Vancomycin                              3 10 2 7 13
  3                                         58 year-old man                                              AV IE with AV ring abscess                                     MSSE AV IE                                                     AV tissue Annulus tissue                                                           Gentamicin Rifampin Vancomycin                                              10 47 47
  4                                         50 year-old man                                                    Brain abscess                                                --                                                       Purulent brain abscess fluid                                                      Ceftriaxone Metronidazole Vancomycin                                            2 2 2
  5                                         51 year-old man                                                        Sepsis                                                   --                                                                 BAL fluid                                                   Clindamycin Levofloxacin Piperacillin/tazo bactam Vancomycin                               2 2 2 2
  6                                        74 year-old woman                                                   Right shoulder                                               --                                                              Synovial fluid                                                        Antibiotics started after shoulder aspiration                                          0
                                      S/P shoulder reconstruction                                             septic arthritis                                                                                                              Synovial tissue                                                                   Ceftriaxone Vancomycin                                                    3 3
  7                                         50 year-old man                                                        Sepsis                                             *S. pneumoniae*                                                             CSF                                                                     Acyclovir Meropenem Vancomycin                                               3 3 3
                                                                                                                                                                        bacteremia                                                           Brain tissue                                                           Acyclovir Ceftriaxone Meropenem Vancomycin                                        7 4 3 7
  8                                         10 year-old male                                                        CAP                                                     --                                                                 BAL fluid                                                                           Azithromycin                                                          5
  9                                         16 year-old male                                                        CAP                                                     --                                                               Pleural fluid                                                                   Azithromycin Ceftriaxone                                                   4 3
  10                                        64 year-old man                                              right TKA septic arthritis              Methicillin resistant coagulase negative *Staphylococcus*      Synovial tissue; posterior femoral tissue; and posterior tibial tissue                                              Cefazolin                                                            1
  11                                        50 year-old man                                                    Right hip AVN                                                --                                                              Synovial fluid                                                               Cefazolin Ceftriaxone Vancomycin                                              1 1 1
  12                                       72 year-old woman                                           Right cranial epidural abscess                                       --                                                              Epidural tissue                                                              Cefazolin Ceftriaxone Vancomycin                                              1 1 1
  13                                          59 year-old                                                        Sepsis and                                           *S. pneumoniae*                                                           CSF \#1                                                                Piperacillin/tazo bactam Vancomycin                                              6 6
                                                 woman                                                           meningitis                                             bacteremia                                                              CSF \#2                                                          Ceftriaxone Piperacillin/ tazobactam Vancomycin                                       14 6 6
  14                                        59 year-old man                                                       Left TKA                                             *Alpha-Strep*                                        Synovial fluid from left knee (before surgery)                                        Antibiotics started after left knee aspiration                                         0
                                                                                                              septic arthritis                                 cultured from left knee fluid                              Retinacular tissue and synovial tissue from the OR                                                        Cefazolin                                                            1
  15                       75 year-old man on chronic suppressive antibiotics                            Recurrent septic left TKA                                MSSA infected left TKA                             Synovial fluid; synovial tissue; and femoral membrane tissue                                         Cefazolin Cephalexin Rifampin                                              6 360 360
  16                                       86 year-old woman                                             Right TKA septic arthritis                               MRSA infected left TKA                                                    Synovial fluid                                                               Cephalexin Clindamycin Linezolid                                             14 14 14
  17                                       70 year-old woman                                                    Encephalitis                                                --                                                                    CSF                                                                         Ceftriaxone Vancomycin                                                    2 2
  18                                       78 year-old woman                                                   Liver abscess                                                --                                                       Purulent liver abscess fluid                                                            Piperacillin/tazobactam                                                     1
  19                                        55 year-old man                                                         CAP                                               MSSA bacteremia                                                          BAL fluid                                                                       Cefazolin Vancomycin                                                     2 2
  20                                       38 year-old woman                                                 Submental abscess                                              --                                                            Swab from I&D in OR                                                                 Clindamycin Vancomycin                                                    2 1
  21                                        78 year-old man                                                      Severe AS                                     Culture negative endocarditis                                                   AV tissue                                                                 Cefazolin Ceftriaxone Vancomycin                                             1 28 28
  22                                        49 year-old man                                                Infective Endocarditis                          *Abiotrophia* *defectiva* bacteremia                                         AV tissue and MV tissue                                                                Cefazolin Vancomycin                                                     2 2
  23                                        79 year-old man                                                        Sepsis                                     *Vibio vulnificans* bacteremia                                  BACTEC^TM^ blood culture bottles (two sets)                                              Piperacillin/tazo bactam Vancomycin                                              2 2
  24                                       69 year-old woman                                             Acute Respiratory failure                                                                                                            ET aspirate                                                         Meropenem Piperacillin/tazo bactam Vancomycin                                        4 3 6
                                                                                                                                                                            --                                                           RLL and LLL BAL fluid                                                    Meropenem Piperacillin/tazo bactam Vancomycin                                        4 4 7
  25                                    40 year-old diabetic man                                                    VAP                             *Streptococcus agalactiae* (initial sputum culture)                                  RLL and LLL BAL fluid                                                     Aztreonam Clindamycin Mer openem Vancomycin                                        6 10 4 4
  26                                       68 year-old woman                                                    CAP and ARDS                                           *E. coli* UTI                                                     RLL and LLL BAL fluid                                                    Azithromycin Ceftriaxone Meropenem Vancomycin                                       6 5 3 5
  27                                        75 year-old man                                                     Necrotizing                                                                                                             Wound aspirate POD \#3                                                Ampicillin/sulbactam Clindamycin Mero penem Vancomycin                                  3 2 1 4
                                  with chronic sacral decubitus ulcer                                            fasciitis                                                  --                                                            Wound swab POD \#15                                            Ampicillin/sulbactam Clindamycin Daptomycin Meropenem Vancomycin                           15 2 12 1 4
  28                          33 year-old man with post-op wound infection                           left ankle pilon fracture S/P ORIF                                     --                                                    Aerobic and anaerobic swabs from OR                                                          Cefazolin Cephalexin                                                     1 7
  29                                  49 year-old quadraplegic man                                         Stage 4 pressure ulcer                                           --                                                      Left hip tissue from I&D in OR                                                     Cephalexin Piperacillin/ tazobactam                                              5 1
  30                                       68 year-old woman                                                   Hypoxemia and                                                                                                                  ET aspirate                                                                      Meropenem Vancomycin                                                     1 1
                                                                                                      hypercapnic respiratory failure                                       --                                                           RLL and LLL BAL fluid                                                          Levofloxacin Meropenem Vancomycin                                              2 1 1
  31                  45 year-old woman with recurrent lower extremity infections                       right knee septic arthritis                                         --                                                   Swab of right knee fluid taken in OR                                                         Levofloxacin Linezold                                                     6 6
  32                                       15 year-old female                                                   Neck abscess                                                --                                                  Right neck abscess tissue excised in OR                                      Azithromycin Cefdinir Clindamycin (po) Clindamycin (IV)                                  5 20 7 2
  33                          91 year-old man with small bowel obstruction                                      RUL collapse                                                --                                                               RUL BAL fluid                                                              Cefepime Metronidazole Vancomycin                                              5 5 4
  34                51 year-old man S/P right to left femoral arterial bypass graft                      post-op left groin seroma                              *S. lugdunensis* bacteremia                                Seroma fluid and Arterial Graft Material from OR                                    Aztreonam Cefazolin Levofloxacin Rifampin Vancomycin                                  2 3 1 5 4
  35                                    74 year-old diabetic man                                               RUE cellulitis                                               --                                                             Right elbow fluid                                                                        TMP/SMX DS                                                           5
  36                                37 year-old woman with CBD leak                                         choledocholithiasis                                             --                                                      Fluid from Peri-biliary abscess                                                     Levofloxacin Meropenem Vancomycin                                              3 5 5
  37                                       74 year-old woman                                                 Right TKA effusion                                             --                                               Right femoral and tibial canal tissue from OR                                             Clindamycin Minocycline Tigecycline                                             1 4 6
  38                           50 year-old woman with RUL Adenocarcinoma                                   Necrotizing pneumonia                                         MSSA VAP                                                    Fluid from right chest cavity                           Ampicillin Ceftriaxone Levofloxacin Piperacillin/tazobactam Meropenem TMP/SMX Vancomycin              5 4 1 7 5 5 5
  39                             25 year-old woman S/P left ankle ORIF                                    left ankle osteomyelitis                                Anaerobic streptococci                                       left ankle abscess tissue collected in OR                                                           Clindamycin                                                           31
  40                                       71 year-old woman                                                      LLL CAP                                                   --                                                       ET aspirate and LLL BAL fluid                                   Azithromycin Ceftriaxone Levofloxacin Piperacillin/tazobactam Vancomycin                        5 9 14 2 2
  41                                    84 year-old diabetic man                              RLE cellulitis and diabetic right foot infection          *Streptococcus agalactiae* (wound culture)                                     Right 5th metatarsal bone                                                   Cefepime Piperacillin/tazobactam Vancomycin                                         1 5 5
  42                 77 year-old woman with end stage renal disease on hemodialysis                            left hip pain.                                               --                                                           left hip joint tissue                                                                      Vancomycin                                                           1
  43         61 year-old man with h/o type A aortic dissection S/P modified Bentall surgery                 Mediastinal abscess                   *Salmonella enterica* serogroup enteritidis bacteremia     Aortic graft material, and fluid and tissue around aortic graft excised in OR                 Ceftriaxone Levofloxacin Piperacillin/tazobactam Vancomycin                               14 18 4 1
  44                       55 year-old man S/P left quadriceps tendon repair                             Left knee septic arthritis                         MSSA cultured from left knee fluid                                         Left knee tissue from OR                                                               Cephalexin Vancomycin                                                     4 5
  45                          56 year-old man with h/o anoxic brain injury                                  respiratory distress                                            --                                                       ET aspirate and RLL BAL fluid                                         Amoxacillin Levofloxacin Piperacillin/tazobactam Vancomycin                                2 1 2 2
  46                      41 year-old man with hypercapnic respiratory failure                                 Drug overdose                                                --                                                       ET aspirate and RLL BAL fluid                                                             Ampicillin/sulbactam                                                      3
  47                               77 year-old woman with lung cancer                                               HCAP                                    *Pseudomonas aeruginosa* pneumonia                                                ET aspirate                                              Amikacin Colistimethate Doripenem Piperacillin/tazobactam Vancomycin                         10 8 5 14 14

**DOT**-- Days of therapy; **POD** -- Post-operative Day; **S/P** -- Status-post; **LP** -- lumbar puncture; **I&D** -- incision and drainage.

**MSSA** -- Methicillin susceptible *Staphylococcus aureus* **; CBD** -- Common bile duct; **TMP/SMX** -- Trimethoprim-Sulfamethoxazole.

**RLE/LLE** -- right/left lower extremity; **TKA**-- Total Knee Arthroplasty; **ORIF**-- Open Reduction and Internal Fixation.

**UTI** -- Urinary tract infection; **AVN** -- avascular necrosis; **IE** -- infective endocarditis; **AV** -- aortic valve; **MV** -- mitral valve.

**CAP**--Community acquired pneumonia; **VAP**--Ventilator associated pneumonia; **HCAP**--Healthcare associated pneumonia.

**BAL** -- bronchoalveolar lavage; **RLL/LLL** -- right/left lower lobe; **ET** -- endotracheal tube; **ARDS** -- acute respiratory distress syndrome.

10.1371/journal.pone.0066349.t002

###### Conventional microbiology versus PCR/ESI-MS test results.

![](pone.0066349.t002){#pone-0066349-t002-2}

        Respiratory and pulmonary specimens                                                                                                                                  
  ---- ------------------------------------- ------------------------------ ------------------------------------------ ----------------------------------------------------- --------
  1                Pleural fluid                  No segs No organisms                      No growth                   *Streptococcus pneumoniae/mitis* Group streptococci     75
  5                  BAL fluid                   Few segs No organisms       Light growth of normal respiratory flora               *Streptococcus pneumoniae*                  54
  8                RLL BAL fluid                 Many segs No organisms                     No growth                               *Streptococcus pneumoniae*                  54
  9             Left pleural fluid               Many segs No organisms                     No growth                                      No detection                         --
  19                 BAL fluid                          Few segs                          Sparse normal                            *S. aureus* (*mec*A negative)                55
                                                      No organisms                      respiratory flora                                  *C. albicans*                       125
                    ET aspirate                  Some segs No organisms       Rare Coagulase negative Staphylococcus                *S. pneumoniae C. albicans*               58 135
  24               RLL BAL fluid                  No segs No organisms                      No growth                                      No detection                         --
                   LLL BAL fluid                  No segs No organisms                      No growth                                      No detection                         --
  25               RLL BAL fluid                 Rare segs No organisms                   *C. glabrata*                                    No detection                         --
                   LLL BAL fluid                 Rare segs No organisms                   *C. glabrata*                                    *C. glabrata*                       1005
  26               RLL BAL fluid                  No segs No organisms                  Rare *C. albicans*                                 *C. albicans*                       140
                   LLL BAL fluid                  No segs No organisms                      No growth                                      *C. albicans*                       141
                    ET aspirate                  Some segs No organisms              Normal respiratory flora                       *S. pneumoniae C. albicans*               58 135
  30               RLL BAL fluid                 Few segs No organisms                      No growth                              *S. vestibularis C. albicans*              98 116
                   LLL BAL fluid                 Rare segs No organisms                     No growth                               *S. pneumoniae C. albicans*               68 112
  33               RUL BAL fluid              Some segs Rare budding yeast              Many *C. albicans*                     *Bifidobacterium dentium C. glabrata*          39 126
  38            Right chest pleural                    Many segs                            Many MSSA                              *S. aureus* (*mec*A negative)                72
                       fluid                       Few budding yeast                    Few *C. albicans*                                  *C. albicans*                       119
                                                       Many segs                              Sparse                                   *Rothia mucilaginosa*                    60
                    ET aspirate                         Rare GPC                     Normal respiratory flora                      *Staphylococcus epidermidis*                 28
                                                                                                                                           *C. albicans*                       899
  40                                                                                                                                   *Rothia mucilaginosa*                    30
                   LLL BAL fluid                 Rare segs No organisms                     No growth                           *S. epidermidis* (*mec*A positive)              12
                                                                                                                                           *C. albicans*                        27
                                                       Many segs                                                                        *Escherichia coli*                     118
                    ET aspirate                         rare GNB                          Many *E. coli*                        *S. epidermidis* (*mec*A positive)              11
  45                                               Many budding yeast                                                                  *Candida tropicalis*                    138
                   RLL BAL fluid                  Many segs, rare GPC                      Some E. coli                                 *Escherichia coli*                     103
                                                   Rare budding yeast                  Many *C. tropicalis*                            *Candida tropicalis*                    138
                                                       Some segs                              Sparse                            viridans/mitis Group streptococcus              95
                    ET aspirate                       No organisms                   Normal respiratory flora                          *Streptococcus* spp.                    137
  46                                                                                                                                       *C. albicans*                       132
                   RLL BAL fluid                  No segs No organisms                      No growth                    viridans/mitis Group streptococcus *C. albicans*     64 61
                                                       Many segs                               Few                                   *Pseudomonas aeruginosa*                  295
  47                ET aspirate                         Rare GNB                     *Pseudomonas aeruginosa*                          *Streptococcus* spp.                     29
                                                                                                                                           *C. albicans*                        25

           Tissue, Fluid, and Orthopedic Specimens                                                                                                                                                                                             
  ---- ----------------------------------------------- --------------------------------- ------------------------------------------------------------------------------------------------- --------------------------------------------------- ------
                       Right shoulder                              Many segs                                                            No                                                              *Propionibacterium acnes*                17
  6                    Synovial fluid                            No organisms                                                         growth                                                              *Acinetobacter junii*                  7
                    Right shoulder tissue                        No organisms                                                        No growth                                                            *Acinetobacter junii*                 188
                       Synovial tissue                             Negative                                                          No growth                                                     *S. epidermidis* (*mec*A positive)            41
  10              Posterior femoral tissue                         Negative                                                          No growth                                                     *S. epidermidis* (*mec*A positive)           201
                   Posterior tibial tissue                   No segs No organisms         Methicillin resistant coagulase negative *Staphylococcus* (one colony in the anaerobic culture)          *S. epidermidis* (*mec*A positive)           113
  11                   Synovial fluid                       Some segs No organisms                                                   No growth                                                                No detection                       --
                       Left knee fluid                   Many segs. Rare GPC in pairs                                      Alpha-hemolytic streptococcus                                    *S. pneumoniae*/viridans/mitis group streptococci   139
  14                Left knee retinaculum                   Rare segs No organisms                                                   No growth                                              *S. pneumoniae*/viridans/mitis group streptococci   135
              Left knee femoral synovial tissue              Few segs No organisms                                                   No growth                                              *S. pneumoniae*/viridans/mitis group streptococci   134
                       Left knee fluid                           No organisms                                                        No growth                                                        *S. aureus* (*mec*A negative)              44
  15              Left knee synovial tissue                 Rare segs No organisms                                                   No growth                                              Low level detection. Unable to identify organism.    --
              Left knee femoral membrane tissue              No segs. No organisms                                                   No growth                                                        *S. aureus* (*mec*A negative)              96
                          Left knee                                 No segs                                                             No                                                            *S. aureus* (*mec*A positive)              34
  16                       tissue                                  Rare GPC                                                           growth                                                              *Acinetobacter junii*                  99
                     Tibial bone tissue                     Few segs. No organisms                                                   No growth                                                                No detection                       --
  18         Fluid aspirated from liver abscess                    Few segs                                              Many *Streptococcus intermedius*                                                 *Streptococcus* spp.                   40
                                                                 No organisms                                           Many *Corynebacterium* spp. not JK                                              *Fusobacterium nucleatum*                58
  20                    Swab from OR                               Negative                                                  *Peptostreptococcus* spp.                                                 *Porphyromonas gingivalis*                48
  27                   Wound aspirate                         Many segs Rare GPC                                                        VRE                                                              *Fusobacterium varium*                  90
                         Wound swab                     Few segs Many RBCs No organisms                            Carbapenem resistant *Klebsiella pneumoniae*                                  *Klebsiella pneumoniae* (*bla* ~KPC-3~)        105
  28                  Swab from OR \#1                      Negative for organisms                                                *Enterobacter*                                                     *Enterobacter cloacae* complex             104
                      Swab from OR \#2                      Negative for organisms                                                *Enterobacter*                                                     *Enterobacter cloacae* complex             105
                                                                   Rare segs                                                         *E. coli*                                                                  *E. coli*                       3888
  29                   Left hip tissue                           No organisms                                                      *E. feacalis*                                                              *E. feacalis*                     138
                                                                                                                                   *B. fragilis*                                                              *B. fragilis*                     2153
  31           Right knee fluid (Swab from OR)              Rare segs No organisms                                                   No growth                                                   *Klebsiella pneumoniae* (*bla* ~KPC-3~)         52
  32             Necrotic lymph node tissue                 Many segs No organisms                                                   No growth                                                                No detection                       --
  35                  Right elbow fluid                     Many segs No organisms                                                   No growth                                                                No detection                       --
  36                    Peri-biliary                               Rare GPC                                                     Many *E. faecalis*                                                       *Enterococcus faecalis*                181
                            fluid                                 in clusters                                               Few *Klebsiella pneumoniae*                                                  *Klebsiella pneumoniae*                 35
  37           Right knee femoral canal tissue               No segs No organisms                                                    No growth                                                                No detection                       --
               Right knee tibial canal tissue                No segs No organisms                                                    No growth                                                            Group G Streptococcus                  11
                                                                   Many segs                                             Many *Streptoccocus mitis/oralis*                                                 *Finegoldia magna*                   181
  39    Tissue from I&D of left ankle abscess in O.R.        Some GPC in clusters                                                    Rare MSSA                                                           *Streptoccocus oralis*                  81
                                                                                                                                                                                                    *Streptococcus infantis/peroris*             74
                                                                   Rare segs                                                  *Staphylococcus aureus*                                                   *Fusobacterium nucleatum*                11
  41     Right 5th metatarsal bone tissue from O.R.                Rare GNB                                                           (MSSA)                                                          *S. aureus* (*mec*A negative)              7
                                                                                                                                                                                                          *Acinetobacter junii*                  12
  42                   Left hip tissue                      Some segs. No organisms                                                  No growth                                                                No detection                       --
  44                  Left knee tissue                      Some segs No organisms                                                   No growth                                                        *S. aureus* (*mec*A negative)              12

          Central Nervous System Specimens                                                                                                                                           
  ---- -------------------------------------- ------------------------------------------- ----------------------------------- ------------------------------------------------------ -----
  2                   CSF \#1                                No organisms                              No growth                           *Streptococcus intermedius*                229
                      CSF \#2                  Gram positive structures resembling cocci               No growth                           *Streptococcus intermedius*                204
  4     Purulent drainage from brain abscess              Many Segs Some GPC               Many *Streptoccocus mitis/oralis*               *Streptococcus intermedius*                164
  7                     CSF                                  No organisms                              No growth               *Streptococcus pneumoniae/Streptococcus mitis* group   208
                    Brain tissue                             No organisms                              No growth               *Streptococcus pneumoniae/Streptococcus mitis* group   145
  12              Epidural tissue                         Many segs Many GPB                Many *Propionibacterium acnes*                  *Propionibacterium acnes*                 184
  13                  CSF \#1                                No organisms                              No growth               *Streptococcus pneumoniae/Streptococcus mitis* group   123
                      CSF \#2                                No organisms                              No growth                                   No detection                       --
  17                    CSF                                  No organisms                              No growth                                   No detection                       --

  --------- ------------------------------------------- ------------------------ ------------------------- ------------------------------------------- --------------------------------------------------
               Cardiac tissue and Vascular specimens                                                                                                   
  Patient                    Specimen                          Gram Stain             Culture results                      PCR/ESI-MS                   Level (GE/well)[\#](#nt107){ref-type="table-fn"}
  3                          AV tissue                     Few segs Rare GPC             No growth             *S. epidermidis* (*mec*A positive)                             185
                          Annulus tissue                 Rare segs No organisms          No growth             *S. epidermidis* (*mec*A positive)                             219
  21                         AV tissue                          Negative                 No growth                        No detection                                        N/A
  22                         AV tissue                      Few GPC Few WBC       *Abiotrophia defectiva*            *Abiotrophia defectiva*                                  113
                             MV tissue                      Few segs Few GPC      *Abiotrophia defectiva*            *Abiotrophia defectiva*                                  121
  23              BACTEC blood culture bottle \#1                 N/A                    No growth                        No detection                                         --
                  BACTEC blood culture bottle \#2                 N/A                    No growth                        No detection                                         --
  34         Fluid from post-op seroma drained in O.R.    No segs No organisms           No growth                        No detection                                         --
             Arterial Graft material extracted in O.R.    No segs No organisms           No growth                *Staphylococcus lugdunensis*                                116
  43             peri-Aortic valve and graft fluid       Rare segs No organisms          No growth                    *Salmonella enterica*                                    30
                   Aortic valve and graft tissue         Rare segs No organisms          No growth          *Salmonella enterica Acinetobacter junii*                        122 12
  --------- ------------------------------------------- ------------------------ ------------------------- ------------------------------------------- --------------------------------------------------

Level of Detection-- Reported as genome equivalents per PCR reaction (GE/well).

LLL  =  Left lower lobe; RLL  =  Right lower lobe; ET aspirate  =  endotracheal aspirate.

CSF  =  cerebrospinal fluid; BAL fluid  =  bronchoalveolar lavage fluid.

Conventional culture methods were non-diagnostic in 33 of 47 cases: in 17 cases cultures were completely negative. Nine of the patients from whom respiratory specimens were collected grew either normal respiratory flora (5), or *Candida* spp. (3), or coagulase negative staphylococci (1). There was only one specimen, an endotracheal tube aspirate, from which an organism was cultured (*C. albicans*), but PCR/ESI-MS testing was negative. PCR/ESI-MS results were negative for detection in six of the 17 culture negative cases.

Bacterial pathogens were detected by PCR/ESI-MS in 60% (33/55) of the specimens in which cultures were either negative or nondiagnostic: *Streptococcus* spp. (17), *Staphylococcus aureus* (5), *Staphylococcus epidermidis* (4), *Staphylococcus lugdunensis* (1), anaerobes (4), *Salmonella enterica* (2), and *bla* ~KPC-3~+ *Klebsiella pneumoniae* (1). In each case, the organism(s) detected by PCR/ESI-MS were consistent with the clinical scenario that was observed in the patient by one of our investigators (JJF). A selection of these cases requires special comment.

Recurrent infections: (Patients 15 and 16) {#s3a}
------------------------------------------

Patients 15 and 16 both were on antimicrobial treatment for presumed relapses of previous *S. aureus* prosthetic knee infections. Although this suspicion was not confirmed by culture, in both cases the previously identified organism (MSSA and MRSA, respectively) was detected by PCR/ESI-MS.

Coagulase-negative staphylococci: (Patients 3 and 10) {#s3b}
-----------------------------------------------------

Coagulase negative staphylococcal infections were suspected in patients 3 and 10. Patient 3 had a history of coronary artery bypass surgery and aortic valve (AV) replacement in 1983. He was well until 2011 when he presented to an outside hospital with fever. He was diagnosed with prosthetic valve infective endocarditis based on the presence of prosthetic aortic valve vegetations and growth of methicillin susceptible *Staphylococcus epidermidis* (MSSE) in two of two sets of blood cultures. He was treated with IV vancomycin and oral rifampin for 30 days, and then transferred to our institution prior for AV replacement surgery. During surgery, Gram positive cocci (GPC) were detected on Gram stain of the valve tissue, but cultures proved to be negative. *Staphylococcus epidermidis* was detected by PCR/ESI-MS in both valve and annular myocardial tissue specimens. Given the presence of prosthetic AV vegetations, CNS in blood cultures obtained before surgery, and GPC in the valve tissue, the detection of MSSE by PCR/ESI-MS is noteworthy and bears significance.

In contrast, the growth of methicillin resistant CNS in the synovial fluid cultures from right knee fluid in patient 10, obtained 10 days prior to initiation of antibiotics, and subsequent negative aerobic intra-operative cultures and growth of only one colony of CNS in one of three anaerobic cultures obtained from during extraction of the infected prosthesis was of uncertain significance. Consideration of PCR/ESI-MS results eliminates any doubt, as MRSE was identified in all three specimens.

Mixed aerobic and anaerobic infections: (Patients 18, 20, 27, 33, 39, 40 and 41) {#s3c}
--------------------------------------------------------------------------------

PCR/ESI-MS detected anaerobic organisms that were missed by culture in eight cases. *Porphyromonas gingivalis* was not appreciated in the culture of neck abscess fluid from patient 20, which was culture negative. And *Bifidobacterium dentium* was detected in BAL fluid from patient 33 that was only notable for *Candida albicans* in culture. *Rothia mucilaginosa* as well as *C. albicans* were identified in the respiratory specimens from patient 40, whose cultures were non-diagnostic (*i*.*e*., normal flora). Culture and PCR/ESI-MS also disagreed on patient 27: VRE was cultured from the original wound culture, but PCR/ESI-MS detected *Fusobacterium varium*.

PCR/ESI-MS performed particularly well with polymicrobic infections that included both aerobic and anaerobic pathogens. *S. intermedius* and MSSA grew in both aerobic and anaerobic cultures, from patients 18 and 41, respectively, but no strictly anaerobic organisms were cultured. *Fusobacterium necrophorum* and *Streptococcus* spp. were detected in purulent liver abscess drainage from patient 18, and MSSA and *F. necrophorum* were identified in the infected metatarsal bone from patient 41. Patient 38 had MSSA and *C. albicans* detected by culture and PCR/ESI-MS in the pleural fluid sample, but *Bilophila wadsworthia* was only detected by PCR/ESI-MS, and not in the anaerobic culture. Likewise, *Streptoccocus oralis* was found in ankle abscess tissue by both aerobic culture and PCR/ESI-MS from patient 39, but only PCR/ESI-MS detected *Finegoldia magna*.

Streptococcal infections: (Patients 1, 2, 4, 5, 7, 8, 13, 14, 18, 30, 37, 39 and 46) {#s3d}
------------------------------------------------------------------------------------

Of the 13 patients (17 samples) from whom *Streptococcus* spp. were detected by PCR/ESI-MS, the only specimens from which *Streptococcus* was recovered by culture were from patients with brief or no antibiotic treatment prior to specimen collection. Two specimens that grew *Streptococcus mitis*/*oralis*: 1) purulent brain abscess drainage from Patient 4 obtained after two days of antibiotic treatment, and 2) the ankle abscess tissue from patient 39-- three days after antibiotics were discontinued. *S. intermedius* was cultured from purulent liver abscess fluid from patient 18 after one day of antibiotic treatment. In patients who had received more than two days of antibiotic treatment, streptococci were no longer cultured. And, in the case of patient 14, one day of treatment was sufficient to suppress growth of streptococci: Left knee synovial fluid cultures from patient 14 grew α-hemolytic streptococci prior to initiation of antibiotics, but after one day of antibiotics, when the knee was drained in the OR, all cultures were negative. PCR/ESI-MS detected viridans streptococci/*S. pneumoniae/mitis* group in three of three surgical specimens from patient 14.

PCR/ESI-MS appeared to offer a particular advantage in detection of pneumococci from both cerebrospinal fluid (CSF), and bronchoalveolar lavage (BAL) fluid. Lumbar puncture (LP) was delayed in two cases of pneumococcal bacteremia and sepsis with presumed meningitis (Patients 7 and 13). In both cases, CSF cultures were negative, but *S. pneumoniae* were detected by PCR/ESI-MS (thereby "salvaging" clinical decision making). Dexamethasone was not administered in either case. Interestingly, PCR/ESI-MS did not remain positive in the CSF indefinitely. CSF from a follow-up LP two weeks later on patient 13 was negative by both culture and PCR/ESI-MS (see [table 2](#pone-0066349-t002){ref-type="table"}). In two cases of apparent pneumococcal pneumonia (Patients 5 and 8) and a third case of viridans streptococcus pneumonia (patient 46), culture was either unable to detect *S. pneumoniae*, or unable to distinguish pathogenic streptococci from normal respiratory flora.

Prosthetic arterial graft infections: (Patients 33 and 43) {#s3e}
----------------------------------------------------------

Infection of prosthetic intravascular graft material is a difficult problem, as vascular grafts are not readily exchanged. Endovascular graft infection was suspected in Patients 33 and 43. Both patients were bacteremic, and both were on antimicrobial treatment prior to surgical extraction of the vascular grafts. Cultures of graft material and surrounding tissue were negative, but in both cases, the organism that had grown in the initial blood cultures was detected by PCR/ESI-MS from the extracted the graft material.

Carbapenem resistant*Enterobacteriaceae* (CRE): (Patients 27 and 31) {#s3f}
--------------------------------------------------------------------

CRE infections were detected in one patient by culture and two patients by PCR/ESI-MS. In patient 27, *K. pneumoniae* that tested positive for KPC-3 by PCR for the *bla* ~KPC~ gene was recovered from an infected surgical wound. PCR/ESI-MS detected both the pathogen (*K. pneumoniae*), and the resistance gene (*bla* ~KPC-3~). Patient 31 was known to be colonized with *bla* ~KPC-3~+ *Klebsiella pneumoniae*, and although cultures of synovial fluid from her right knee were negative, PCR/ESI-MS detected *K. pneumoniae* (also positive for *bla* ~KPC-3~).

Extended antibiotic treatment and serial specimens: (Patients 13 and 32) {#s3g}
------------------------------------------------------------------------

Just as with culture, duration of antibiotic treatment does influence ability of PCR/ESI-MS to detect evidence of a pathogen. In the case of serial CSF samples from patient 13, a patient with *S. pneumoniae* bacteremia and sepsis, *S. pneumoniae* was only detected by PCR/ESI-MS in the first CSF sample. In the case of patient 32, both culture and PCR/ESI-MS of neck abscess tissue were negative after more than 34 days of empiric antibiotic treatment.

*Acinetobacter junii*: (Patients 6, 16, 41, 43) {#s3h}
-----------------------------------------------

In these four cases *Acinetobacter junii* was detected by PCR/ESI-MS in tissue and synovial fluid specimens collected during surgical resection and drainage of infected tissue. *Acinetobacter junii* is unlikely to represent a pathogen in these cases. This organism appears to have been detected as an artifact of the tissue extraction process.

Discussion {#s4}
==========

PCR/ESI-MS is an emerging diagnostic technology that is capable of rapid detection of microorganisms directly from clinical specimens. As this PCR-based approach requires only the presence of small amounts of DNA for amplification, bacteria that have been "killed" by bactericidal antibiotics (*e*.*g*., β-lactams, aminoglycosides or quinolones) or are in stationary phase from the effect of bacteriostatic drugs (*e*.*g*., linezolid, macrolides) can be detected if sufficient DNA for amplification is present in the sample. Up to this time, data testing this assertion in the clinical arena have not yet been provided.

In our series, 72% (55/76) of cultures obtained following initiation of antimicrobial treatment were nondiagnostic. In contrast, PCR/ESR-MS detected organisms in 83% (39/47) of cases and 76% (58/76) of the specimens. Calculation of the Kappa coefficient confirmed poor agreement between conventional cultures and PCR/ESI-MS. The poor agreement is primarily attributable to detection of bacteria by PCR/ESI-MS in culture negative specimens. PCR/ESI-MS detected ≥ one bacterial pathogen(s) in 60% (27/45) of the culture negative specimens. In 67% of negative culture cases (18/27), an organism that was consistent with the clinical scenario was detected by PCR/ESI-MS.

Reliance on clinical judgment to distinguish colonizers and contaminants from true pathogens is required with any microbiology test result. As with culture-based identification of organisms from clinical samples, the correct interpretation of PCR/ESI-MS results requires an appreciation for the clinical context associated with the specimen tested. In several cases the organisms detected by PCR/ESI-MS were consistent with contaminants that would have been unlikely to alter patient management. For example, detection of *Candida* spp. in respiratory secretions by either culture or molecular methods does not merit treatment in our relatively immunocompetent patient population. But, as evidenced in the case of Patient 6, the role of other potential pathogens still needs to be defined. In this case, low level detection (17 genome copies/well) of *Propionibacterium acnes*, a pathogen with well described association with prosthetic shoulder joint infections, in culture negative right shoulder synovial fluid would pose a challenge for the clinician responsible for interpreting this additional data.

Selecting appropriate antimicrobial therapy for patients with evidence of infection, but negative cultures is a common dilemma in practice. The implications of our findings are profound: that antimicrobial treatment in "culture negative" cases can be directed against both pathogens and genetic markers of resistance (*i*.*e*., *mec*A in MRSA, mutations in *qrdr*, *bla* ~KPC~, etc.) that are readily identified by PCR/ESI-MS. Particularly compelling supporting evidence for pathogen detection derives from our two cases of breakthrough recurrent prosthetic knee infections that occurred while the patients were taking chronic suppressive antibiotics (patients 15 and 16): the previous organism was not recovered in tissue cultures taken during extraction of the infected knee prostheses in either case, but was detected by PCR/ESI-MS. As well as our case of culture and Gram stain positive streptococcal septic arthritis (Patient 14), in which a single preoperative dose of cefazolin was sufficient to cause surgical cultures to be negative. The disappearance of PCR evidence of *S. pneumoniae* in a second CSF specimen from patient 13, who was recovering from pneumococcal bacteremia and sepsis, suggests that organism detection may be eradicated with effective antimicrobial treatment. This finding may help with decisions to tailor and/or stop therapy. These early findings could have impact on the current status of "duration of therapy" and antibiotic stewardship.

Limitations of this study include: *i*) the small sample size and lack of a control group; *ii*) relevance of "mixed cultures"; and *iii*) co-identification of streptococci (viridians streptococci, *Streptococcus mitis* and pneumococcus). This study was performed as an open investigation, and not a validation; and is not appropriate for, nor was it designed to calibrate sensitivity or specificity. Our PCR primers successfully captured organisms not detected by culture, but we maintain that microbiological culture results are still the "gold standard" for comparison. Based upon studies such as this, that "standard" cannot be applied as the evidence it offers is not present, but combining broad range PCR with mass spectrometry or 16S ribosomal gene sequencing has appeal for selected situations in the clinical microbiology lab. In addition, the role of fungal, viral or parasitic infections was also not evaluated in this small series. Truly, larger studies are needed.

The everyday practice of treating patients with empiric antibiotic regimes provides an enormous opportunity for novel approaches to target antimicrobial therapy and "salvage" both individual treatment regimens as well as institutional antimicrobial stewardship efforts. These results suggest that PCR/ESI-MS may have a role in detection of clinically relevant pathogens from specimens obtained following initiation of antimicrobial treatment when cultures are negative. Larger studies are planned to determine if PCR/ESI-MS can assist in the clinical evaluation and treatment of patients on empiric antimicrobial treatment for suspected infection with negative cultures.

The Kappa calculation of agreement was performed on SAS software with the assistance of Huagping Wang, Ph.D. Department of Medicine. University of Illinois College of Medicine.

PCR/ESI-MS testing was performed by Kristin S. Lowery, Ph.D at Ibis Biosciences, a Division of Abbott Molecular, Inc., in Carlsbad, CA, USA.
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